Research Paper Volume 16, Issue 3 pp 2232—2248
Identification of an immune-related eRNA prognostic signature for clear cell renal cell carcinoma
Figure 5. Clinical and prognostic characteristics of AC003092.1 in ccRCC. (A–C) KM survival curve showing the survival differences between high and low AC003092.1 groups (A: OS; B: DSS; C: PFI); (D) Difference of AC003092.1 mRNA expression between ccRCC and adjacent tissues; (E) KM survival curve showing the survival differences between high and low TFPI2 groups; (F–J) Differences of AC003092.1 expression in different clinicopathological variables (F: Grade; G: Stage; H: T stage; I: M stage; J: N stage); (K, L) KM survival curve showing the survival differences between high and low AC003092.1 groups in the E-MTAB-1980 and ICGC datasets.